Actinium Pharmaceuticals $ATNM Another Promising Name In The AML Space

While this has been a mixed year for the biotechnology sector, there have been some clear winners. Celator Pharmaceuticals Inc. (NASDAQ: CPXX) is one such winner. In fact, CPXX is one of the most phenomenal stories in the biotech sector this year. paymentdatasystems-650x535 Before it was acquired by Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) earlier in the year, CPXX returned investors more than 1600% this year.

The phenomenal run in CPXX began in March this year after the company announced top-line results for its lead product candidate VYXEOS. When the company released expanded data for the lead product candidate, shares jumped another 50%. In May this year, CPXX agreed to be acquired by Jazz for more than $30 per share. From just above $1.50 per share to more than $30 per share within a matter of months. Read more